Evidence map›Paper›PMID 26893822›Full record

ArticleSkeletal muscle2016

Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle.

Yana Konokhova, Sally Spendiff, R Thomas Jagoe, Sudhakar Aare, Sophia Kapchinsky, Norah J MacMillan, Paul Rozakis, Martin Picard, Mylène Aubertin-Leheudre, Charlotte H Pion and 3 more

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Deaccelerated Myogenesis and Autophagy in Genetically Induced Pulmonary Emphysema.American journal of respiratory cell and molecular biology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician.International journal of chronic obstructive pulmonary disease · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Muscle Oxidative Capacity Is Reduced in Both Upper and Lower Limbs in COPD.Medicine and science in sports and exercise · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yana Konokhova *Department of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
Sally Spendiff *Department of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
R Thomas JagoeDepartments of Oncology and Medicine, McGill University, Montreal, Canada.
Sudhakar AareDepartment of Critical Care Medicine, McGill University Health Center, Montreal, Canada.
Sophia KapchinskyDepartment of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
Norah J MacMillanDepartment of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
Paul RozakisDepartment of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
Martin PicardDivision of Behavioral Medicine, Department of Psychiatry, Department of Neurology, and Columbia Translational Neuroscience Initiative, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York, NY USA.
Mylène Aubertin-LeheudreDépartement de Kinanthropologie, Université du Québec à Montréal, Montreal, Canada.
Charlotte H PionDépartement de Kinanthropologie, Université du Québec à Montréal, Montreal, Canada.
Jean BourbeauRespiratory Epidemiology and Clinical Research Unit, Center for Innovative Medicine (CIM), McGill University Health Centre, Montreal, Canada.
Russell T HeppleDepartment of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
Tanja TaivassaloDepartment of Kinesiology, McGill University, 475 Pine Ave West, Room 222, Montreal, Quebec H2W1S4 Canada.
McGill University · CAMcGill University Health Centre · CAUniversité du Québec à Montréal · CAColumbia University Irving Medical Center · US

Funding

Canadian Institutes of Health Research 162111
6 · The paper itself

Abstract

backgroundLow mitochondrial content and oxidative capacity are well-established features of locomotor muscle dysfunction, a prevalent and debilitating systemic occurrence in patients with chronic obstructive pulmonary disease (COPD). Although the exact cause is not firmly established, physical inactivity and oxidative stress are among the proposed underlying mechanisms. Here, we assess the impact of COPD pathophysiology on mitochondrial DNA (mtDNA) integrity, biogenesis, and cellular oxidative capacity in locomotor muscle of COPD patients and healthy controls. We hypothesized that the high oxidative stress environment of COPD muscle would yield a higher presence of deletion-containing mtDNA and oxidative-deficient fibers and impaired capacity for mitochondrial biogenesis.

methodsVastus lateralis biopsies were analyzed from 29 COPD patients and 19 healthy age-matched controls for the presence of mtDNA deletions, levels of oxidatively damaged DNA, mtDNA copy number, and regulators of mitochondrial biogenesis as well the proportion of oxidative-deficient fibers (detected histologically as cytochrome c oxidase-deficient, succinate dehydrogenase positive (COX(-)/SDH(+) )). Additionally, mtDNA copy number and mitochondrial transcription factor A (TFAM) content were measured in laser captured COX(-)SDH(+) and normal single fibers of both COPD and controls.

resultsCompared to controls, COPD muscle exhibited significantly higher levels of oxidatively damaged DNA (8-hydroxy-2-deoxyguanosine (8-OHdG) levels = 387 ± 41 vs. 258 ± 21 pg/mL) and higher prevalence of mtDNA deletions (74 vs. 15 % of subjects in each group), which was accompanied by a higher abundance of oxidative-deficient fibers (8.0 ± 2.1 vs. 1.5 ± 0.4 %). Interestingly, COPD patients with mtDNA deletions had higher levels of 8-OHdG (457 ± 46 pg/mL) and longer smoking history (66.3 ± 7.5 years) than patients without deletions (197 ± 29 pg/mL; 38.0 ± 7.3 years). Transcript levels of regulators of mitochondrial biogenesis and oxidative metabolism were upregulated in COPD compared to controls. However, single fiber analyses of COX(-)/SDH(+) and normal fibers exposed an impairment in mitochondrial biogenesis in COPD; in healthy controls, we detected a marked upregulation of mtDNA copy number and TFAM protein in COX(-)/SDH(+) compared to normal fibers, reflecting the expected compensatory attempt by the oxidative-deficient cells to increase energy levels; in contrast, they were similar between COX(-)/SDH(+) and normal fibers in COPD patients. Taken together, these findings suggest that although the signaling factors regulating mitochondrial biogenesis are increased in COPD muscle, impairment in the translation of these signals prevents the restoration of normal oxidative capacity.

conclusionsSingle fiber analyses provide the first substantive evidence that low muscle oxidative capacity in COPD cannot be explained by physical inactivity alone and is likely driven by the disease pathophysiology.

Indexed as

Oxidative StressAgedCase-Control StudiesDNA-Binding ProteinsDNA DamageDNA, MitochondrialElectron Transport Complex IVFemaleHumansMaleMiddle AgedMitochondrial ProteinsMitochondria, MuscleMuscle Fibers, SkeletalOrganelle BiogenesisPulmonary Disease, Chronic ObstructiveDNA-Binding ProteinsDNA, MitochondrialElectron Transport Complex IVMitochondrial ProteinsSuccinate DehydrogenaseTFAM protein, humanTranscription FactorsChronic obstructive pulmonary diseaseCOX deficiencyLaser capture microscopyMitochondrial biogenesisMitochondrial DNAmtDNA copy numberMuscle oxidative impairmentOxidative stressTFAM

Identifiers

PMID26893822
PMCPMC4758107
OpenAlexW2283053705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.